| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2823409 | 1 | M | PA | 01/28/2025 |
MMRV |
MERCK & CO. INC. |
Y010247 |
Rash, Rash vesicular, Varicella virus test positive
Rash, Rash vesicular, Varicella virus test positive
|
Vesicular rash from R pubic/groin down R lateral thigh to knee
Vesicular rash from R pubic/groin down R lateral thigh to knee
|
||||||
| 2822894 | 1.25 | U | PA | 01/27/2025 |
MMR |
MERCK & CO. INC. |
Y010046 |
No adverse event, Syringe issue
No adverse event, Syringe issue
|
caller unsure if patient received full amount of dose as some of the diluent leaked out due to the s...
caller unsure if patient received full amount of dose as some of the diluent leaked out due to the suction; syringe experienced suction when twisting the needle onto the hub of syringe causing cap; caller unsure if patient received full amount of dose as some of the diluent leaked out due to the suction; device fluid leak; no adverse event; This spontaneous report was received from registered nurse and refers to a 15-month-old. patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot #Y010046, expiration date: 29-MAY-2026, administered for prophylaxis (strength, and route of administration were not provided), status albumin- rHA; and sterile diluent (BAXTER STERILE DILUENT) solution for injection/infusion, lot #1973242, expiration date: 17-FEB-2026 (strength, route of administration, and indication were not provided). On an unknown date, the sterile diluent syringe experienced suction when twisting the needle onto the hub of syringe causing cap of syringe to pop off. The nurse reported that a dose of M-M-R-II was administered to a patient that was reconstituted using the defective sterile diluent syringe and caller unsure if patient received full amount of dose as some of the diluent leaked out due to the suction. No adverse events reported.
More
|
||||||
| 2822895 | U | 01/27/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Malaise
Malaise
|
I got sick; This non-serious case was reported by a consumer via interactive digital media and descr...
I got sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: I got sick). The outcome of the sickness was not reported. It was unknown if the reporter considered the sickness to be related to Shingles vaccine. It was unknown if the company considered the sickness to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 07-JAN-2025 This case was reported by a patient via interactive digital media. The patient got sick after his/her shingles shot but it was nothing compared to getting actual shingles.
More
|
||||||||
| 2822896 | U | 01/27/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspected vaccination failure; the vaccination didn't stop it for me; This serious case was rep...
Suspected vaccination failure; the vaccination didn't stop it for me; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: the vaccination didn't stop it for me). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure and shingles to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 13-JAN-2025 This case was reported by a patient via interactive digital media. The patient reported that the vaccination did not stop it for him/her. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. Herpes zoster is an unlisted event which is considered unrelated to GSK Shingles vaccine.
More
|
||||||||
| 2822897 | M | VA | 01/27/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
received first dose of shingles vaccine January 18th 2024; This non-serious case was reported by a c...
received first dose of shingles vaccine January 18th 2024; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 55-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (Patient received first dose on 18-JAN-2024). On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: received first dose of shingles vaccine January 18th 2024). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 03-JAN-2025 Patient received first dose of shingles vaccine brand, lot number and expiration date was unknown on January 18th 2024 and he forgot to get the second dose 6 months later. Till the time of reporting the patient did not receive second dose of Shingles vaccine which led to incomplete course of vaccination.
More
|
|||||||
| 2822898 | F | CO | 01/27/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
Inappropriate schedule of vaccine; This non-serious case was reported by a pharmacist via call cente...
Inappropriate schedule of vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (first dose of Shingrix about 2.5 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 06-JAN-2025 Till the time of reporting the patient had not received the second dose of Shingrix, which led to incomplete course of vaccination. The reporter asked what were the recommendations as to if she should receive her second dose since it's way outside of the 2 to 6 month window. The reporter consented to follow up.
More
|
|||||||
| 2822899 | F | PA | 01/27/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
2345B |
Incorrect dose administered
Incorrect dose administered
|
0.5mL of an adult Havrix dose to a 16 year old female patient; This non-serious case was reported by...
0.5mL of an adult Havrix dose to a 16 year old female patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 16-year-old female patient who received HAV (Havrix adult) (batch number 2345B, expiry date 02-FEB-2026) for prophylaxis. On 02-DEC-2024, the patient received the 2nd dose of Havrix adult. On 02-DEC-2024, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: 0.5mL of an adult Havrix dose to a 16 year old female patient). The outcome of the adult product administered to child was unknown. Additional Information: GSK receipt date: 08-JAN-2025 The physician reported that 0.5mL of an adult Havrix dose to a 16 year old female patient because they did not stock the pediatric formulation in the office, which led to adult product administered to child.
More
|
|||||||
| 2822900 | U | NM | 01/27/2025 |
HEPAB |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
no second dose was administered; This non-serious case was reported by a pharmacist via call center ...
no second dose was administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose of Twinrix vaccine on March 2024). On an unknown date, the patient did not receive Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: no second dose was administered). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-JAN-2025 The Healthcare professional reported on the day of reporting, 10th January 2025 that a patient received the first dose of Twinrix on March 2024 and had not received the second dose. The reporter was called to made clinical decision, no second dose was administered at the moment of the call yet. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination.
More
|
|||||||
| 2822908 | 27 | M | CA | 01/27/2025 |
ANTH |
EMERGENT BIOSOLUTIONS |
|
Injection site erythema, Injection site induration, Injection site swelling
Injection site erythema, Injection site induration, Injection site swelling
|
Large local reaction at injection site, characterized by firm swelling >6 cm and mild erythema, n...
Large local reaction at injection site, characterized by firm swelling >6 cm and mild erythema, no pain. Resolved with conservative care over 3 days. Refer to DHA IHD
More
|
||||||
| 2822915 | U | MI | 01/27/2025 |
HIBV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Expired product administered
Expired product administered
|
expired dose administered; This non-serious case was reported by a other health professional via cal...
expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received Hib (Hiberix) (expiry date 14-DEC-2024) for prophylaxis. On 16-DEC-2024, the patient received Hiberix. On 16-DEC-2024, an unknown time after receiving Hiberix, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 09-JAN-2025 The reporter reported that the patient was administered Hiberix two days after expiration date which led to, expired vaccine used. The health care professional did not had patient details or lot number of the suspect.
More
|
|||||||
| 2822918 | 72 | M | MA | 01/27/2025 |
FLU3 RSV |
SEQIRUS, INC. PFIZER\WYETH |
388493 KD0161 |
Mobility decreased, Pain; Mobility decreased, Pain
Mobility decreased, Pain; Mobility decreased, Pain
|
Patient came to pharmacy on 1/24/25 complaining that from the day after he received the RSV (abrysvo...
Patient came to pharmacy on 1/24/25 complaining that from the day after he received the RSV (abrysvo) vacine he has experienced pain and has not been able to raise his arm above shoulder height. Patient will be visiting primary MD in the coming weeks. Patient states that the pain has not resolved.
More
|
||||||
| 2822971 | 80 | M | IA | 01/27/2025 |
COVID19 |
MODERNA |
3043159 |
Death
Death
|
Death
Death
|
โ | |||||
| 2822972 | 12 | F | IN | 01/27/2025 |
PNC13 |
PFIZER\WYETH |
|
Injection site erythema, Injection site pain, Injection site swelling
Injection site erythema, Injection site pain, Injection site swelling
|
Swollen, red and painful shoulder at sight of injection
Swollen, red and painful shoulder at sight of injection
|
||||||
| 2822973 | 11 | F | MI | 01/27/2025 |
FLU4 FLU4 |
SANOFI PASTEUR SANOFI PASTEUR |
ut8408ja ut8408ja |
Blood glucose decreased, Chills, Dizziness, Fatigue, Flushing; Hyperhidrosis, Le...
Blood glucose decreased, Chills, Dizziness, Fatigue, Flushing; Hyperhidrosis, Lethargy
More
|
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mil...
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: patient was 11 years upon questioning her she indicated that she did not have breakfast or anything to eat prior to receiving the flu shot , ems arrived and upon taking the patient glucose level it was trending low 68 , patient was instructed by ems to have some orange juice and some crackers patient received some at the pharmacy and was feeling better after, Other Vaccines: VaccineTypeBrand: Fluzone; Manufacturer: sanofi; LotNumber: ut8408ja; Route: im; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
More
|
||||||
| 2822974 | 71 | M | IN | 01/27/2025 |
RSV |
PFIZER\WYETH |
hn8090 |
Hypoaesthesia, Paraesthesia, Walking aid user
Hypoaesthesia, Paraesthesia, Walking aid user
|
Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial a...
Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: pt spent time in hospital numb & tingly in both legs and feet-worse in right leg. using a walker now but hoping to recover
More
|
โ | |||||
| 2822975 | 36 | F | FL | 01/27/2025 |
HPV9 |
MERCK & CO. INC. |
y007197 |
Loss of consciousness, Nausea, Syncope, Unresponsive to stimuli
Loss of consciousness, Nausea, Syncope, Unresponsive to stimuli
|
Systemic: Fainting / Unresponsive-Mild, Systemic: pt fainted about 3 minutes after shot and recovere...
Systemic: Fainting / Unresponsive-Mild, Systemic: pt fainted about 3 minutes after shot and recovered quickly with water and fan air-Mild, Systemic: Nausea-Mild, Additional Details: Patient past out after being administered 2 vaccines shingles and Gardasil in the same arm left deltoid, by tech. After administration she was packing up and fainted. We help her up and she recovered quickly, and asked what happened and she felt like vomitting. We provided her with water and a fan to cool due to wet clothing. I asked if she could be pregnant she stated no. She laid on the floor for a 10minutes, then left and I called and about 2 hours after and she states she is ok., Other Vaccines: VaccineTypeBrand: shingrix; Manufacturer: gsk; LotNumber: 4h79y; Route: im; BodySite: left deltoid; Dose: 1; VaxDate: 01/18/2025
More
|
||||||
| 2822976 | 85 | F | CT | 01/27/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
LN4P2 |
Atrial fibrillation, Tachycardia
Atrial fibrillation, Tachycardia
|
Systemic: Patient experienced atrial fibrillation-Medium, Systemic: Tachycardia-Medium, Additional D...
Systemic: Patient experienced atrial fibrillation-Medium, Systemic: Tachycardia-Medium, Additional Details: Patient called to report that she experienced AFib and tachycardia (110 bpm at rest) and wanted to know if it was associated with the RSV vaccine she received 1 day prior. The event was resolved by the patient when she took an extra dose of metoprolol and diazepam. She contacted the pharmacy after the event. The pharmacist recommended that she follows-up with her cardiologist (who she has an appointment with next month) on the next business day.
More
|
||||||
| 2822977 | 56 | F | NM | 01/27/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
74nc9 |
Cellulitis, Injection site erythema, Injection site pain
Cellulitis, Injection site erythema, Injection site pain
|
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: Pat...
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: Patient stated she works in the ER department and physician there said she got cellulitis from vaccine. Injections was given vaccine intramuscularly. I explained to her its common to develop rash and redness at injection site with shingrix vaccine. It looked like a normal reaction to vaccine site. Patient was not seeking compensation just thought we should be aware of situation., Other Vaccines: VaccineTypeBrand: prevnar 20; Manufacturer: wyeth/pfizer; LotNumber: lp8151; Route: intramuscular; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
More
|
||||||
| 2822978 | 69 | F | TX | 01/27/2025 |
RSV RSV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
x4ea5 x4ea5 |
Injection site bruising, Injection site erythema, Injection site induration, Inj...
Injection site bruising, Injection site erythema, Injection site induration, Injection site inflammation, Injection site pain; Injection site pruritus, Injection site scab, Injection site swelling
More
|
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injec...
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient presented on 01/19/2025 with wound that was scabbed over. patient stated that it progressed from red inflamed bruised knot to open sore to scabbed over, Other Vaccines: VaccineTypeBrand: singrix; Manufacturer: glaxo; LotNumber: kb2yt; Route: im; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN
More
|
||||||
| 2822979 | 55 | F | NJ | 01/27/2025 |
FLUC4 FLUC4 |
SEQIRUS, INC. SEQIRUS, INC. |
946635 946635 |
Dermatitis allergic, Injection site erythema, Injection site pruritus, Injection...
Dermatitis allergic, Injection site erythema, Injection site pruritus, Injection site swelling, Pruritus; Rash
More
|
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at In...
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Other Vaccines: VaccineTypeBrand: Flucelvax; Manufacturer: sequiris; LotNumber: 946635; Route: im; BodySite: left deltoid; Dose: 1; VaxDate: 01/11/2025, VaccineTypeBrand: Pfizer Covid 19 2024-2025; Manufacturer: pfizer; LotNumber: lp1780; Route: im; BodySite: left deltoid; Dose: 1; VaxDate: 01/11/2025
More
|
||||||
| 2822980 | 81 | F | FL | 01/27/2025 |
FLU4 |
SANOFI PASTEUR |
u8532ca |
Injection site bruising, Injection site pain, Injection site swelling
Injection site bruising, Injection site pain, Injection site swelling
|
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Inje...
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium
More
|
||||||
| 2822981 | 37 | F | AZ | 01/27/2025 |
HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
y013712 y013712 |
Asthenia, Fatigue, Injection site erythema, Injection site pain, Injection site ...
Asthenia, Fatigue, Injection site erythema, Injection site pain, Injection site pruritus; Injection site swelling, Lethargy
More
|
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection ...
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild, Systemic: Exhaustion / Lethargy-Severe, Systemic: Weakness-Severe
More
|
||||||
| 2822982 | 45 | F | FL | 01/27/2025 |
COVID19-2 |
PFIZER\BIONTECH |
lp1780 |
Lymphadenopathy
Lymphadenopathy
|
Systemic: Lymph Node Swelling-Mild
Systemic: Lymph Node Swelling-Mild
|
||||||
| 2822983 | 64 | F | CA | 01/27/2025 |
COVID19 |
MODERNA |
0000 |
Dizziness, Fatigue, Lethargy
Dizziness, Fatigue, Lethargy
|
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium
|
||||||
| 2822984 | 61 | F | MD | 01/27/2025 |
COVID19 |
PFIZER\BIONTECH |
0000 |
Chills, Pain, Pyrexia
Chills, Pain, Pyrexia
|
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium
|
||||||
| 2822985 | 70 | M | MI | 01/27/2025 |
COVID19 |
MODERNA |
0000 |
Rash
Rash
|
Systemic: Allergic: Rash Generalized-Medium
Systemic: Allergic: Rash Generalized-Medium
|
||||||
| 2822986 | 64 | F | VA | 01/27/2025 |
PNC20 |
PFIZER\WYETH |
LP8151 |
Injection site pain
Injection site pain
|
Site: Pain at Injection Site-Mild
Site: Pain at Injection Site-Mild
|
||||||
| 2822987 | 36 | M | IL | 01/27/2025 |
COVID19 |
MODERNA |
7654321 |
Myocardial infarction
Myocardial infarction
|
Systemic: Not Covid, vaccine unknown. Per patent's Cardiologist, he cannot take any vaccines d...
Systemic: Not Covid, vaccine unknown. Per patent's Cardiologist, he cannot take any vaccines due to heart complications from previous vaccines.-Severe, Systemic: Heart Attack-Severe
More
|
||||||
| 2822988 | 75 | M | MN | 01/27/2025 |
PNC21 |
MERCK & CO. INC. |
Y013009 |
Asthenia, Injection site erythema, Nausea
Asthenia, Injection site erythema, Nausea
|
Site: Redness at Injection Site-Medium, Systemic: weakness and nausea-Medium, Systemic: Nausea-Mediu...
Site: Redness at Injection Site-Medium, Systemic: weakness and nausea-Medium, Systemic: Nausea-Medium, Systemic: Weakness-Medium, Additional Details: Patient received Arexy and Capvaxive in the left deltoid on 1/18/25 at 3:49pm. Patient denies ever having soreness, tenderness or pain. Sunday night, 1/19/25, patient says he began to feel weakness and nausea, of which worsened by Monday, 1/20/25. Went to the doctor on Tuesday, 1/21/25, and diagnosed with redness of the arm and potential cellulitis. Being treated with cephalexin for 5 days starting afternoon of 1/21/25., Other Vaccines: VaccineTypeBrand: Arexvy; Manufacturer: GSK; LotNumber: 4BN95; Route: IM; BodySite: left arm; Dose: 1; VaxDate: 01/18/2025
More
|
||||||
| 2822989 | 37 | M | NY | 01/27/2025 |
FLUC4 |
SEQIRUS, INC. |
946636 |
Injection site bruising, Injection site pain, Injection site swelling
Injection site bruising, Injection site pain, Injection site swelling
|
Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Swelling at Inje...
Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe
More
|
||||||
| 2822991 | 80 | F | PA | 01/27/2025 |
COVID19 |
MODERNA |
10232024 |
Fatigue, Lethargy, Pain, Pyrexia
Fatigue, Lethargy, Pain, Pyrexia
|
Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Mil...
Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Mild
More
|
||||||
| 2822992 | 76 | F | TX | 01/27/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
3043823 3043823 |
Back pain, Blood pressure increased, Dizziness, Dyspnoea, Hyperventilation; Musc...
Back pain, Blood pressure increased, Dizziness, Dyspnoea, Hyperventilation; Muscle spasms, Muscle tightness, Pain
More
|
Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Body Aches Generalized-Severe, Systemic: ...
Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Patient had muscle spasms ans tightness below the waist, lower back pain, elevated blood pressure-Severe, Systemic: Hyperventilation-Medium, Additional Details: Muscle Spasms below the waist, back pain, elevated blood pressure, breathing heavy, light headed, Other Vaccines: VaccineTypeBrand: moderna; Manufacturer: moderna; LotNumber: 3043823; Route: Intramuscular; BodySite: Left Deltoid; Dose: 4; VaxDate: 01/22/2025
More
|
||||||
| 2822993 | 67 | F | PA | 01/27/2025 |
COVID19 |
PFIZER\BIONTECH |
LM7786 |
Pruritus
Pruritus
|
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Genera...
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Additional Details: Pt has received initial vaccines and all booster doses (all pfizer) and reported ongoing full body itchiness since administration date of latest vaccine (10/18/24). has seen PCP and dermatologist, has tried topical creams and oral medications to stop itching with no improvement
More
|
||||||
| 2822994 | 19 | M | CA | 01/27/2025 |
FLUC4 |
SEQIRUS, INC. |
946619 |
Dizziness, Pallor, Pyrexia
Dizziness, Pallor, Pyrexia
|
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Mild, Additional Details: Patient experi...
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Mild, Additional Details: Patient experienced dizziness, fever, and his skin turned pale. He sat more than 15 minutes until he felt better and left. He did not want to call 911.
More
|
||||||
| 2822995 | 66 | F | MI | 01/27/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
0000 0000 |
Asthenia, Fatigue, Headache, Lethargy, Pain; Pyrexia
Asthenia, Fatigue, Headache, Lethargy, Pain; Pyrexia
|
Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Med...
Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium, Systemic: Weakness-Medium
More
|
||||||
| 2822996 | 54 | F | FL | 01/27/2025 |
COVID19 |
PFIZER\BIONTECH |
0000 |
Chills, Fatigue, Lethargy
Chills, Fatigue, Lethargy
|
Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium
Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium
|
||||||
| 2822997 | 61 | M | CA | 01/27/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
022J21A 022J21A |
Angina pectoris, Chest pain, Fatigue, Lethargy, Palpitations; Tachycardia
Angina pectoris, Chest pain, Fatigue, Lethargy, Palpitations; Tachycardia
|
Systemic: Exhaustion / Lethargy-Medium, Systemic: Tachycardia-Medium, Additional Details: PATIENT RE...
Systemic: Exhaustion / Lethargy-Medium, Systemic: Tachycardia-Medium, Additional Details: PATIENT REPORTS HAVING HEART/CHEAT PAIN, PALPITATIONS, AND EXAUHSTION W/IN 2 DAYS OF COVAX. HE WENT TO THE ER AS A RESULT. & HAS SINCE DECIDED NOT TO GET VACCINATED FOR COVID.
More
|
||||||
| 2822998 | 52 | F | RI | 01/27/2025 |
FLUR4 |
PROTEIN SCIENCES CORPORATION |
U8432AA |
Trigeminal neuralgia
Trigeminal neuralgia
|
Systemic: Neurological Disorder (diagnosed by MD)-Medium, Additional Details: Patient reports experi...
Systemic: Neurological Disorder (diagnosed by MD)-Medium, Additional Details: Patient reports experiencing left-sided facial neuralgia 10-15 minutes post-vaccination. Most symptomatic, throughout the first week post-vaccination. Continued on/off for two months post-vaccination. Patient received full work-up for stroke/TIA with neurologist. Neurologist confirmed no neurological deficits indicative of stroke/TIA; informed patient to contact pharmacy as believes neuralgia a result of vaccine-related adverse event.
More
|
||||||
| 2822999 | 49 | F | TX | 01/27/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
|
Antinuclear antibody, Differential white blood cell count, Full blood count, Ras...
Antinuclear antibody, Differential white blood cell count, Full blood count, Rash, Swelling face; Urticaria
More
|
Rash/hives, facial swelling
Rash/hives, facial swelling
|
||||||
| 2823000 | 19 | F | IN | 01/27/2025 |
MENB MENB |
NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS |
3L339 3L339 |
Blood iron abnormal, Dizziness, Electrocardiogram, Full blood count normal, Head...
Blood iron abnormal, Dizziness, Electrocardiogram, Full blood count normal, Headache; Insomnia, Nausea, Paraesthesia, Presyncope
More
|
12 hours post vaccine administration- vasovagal/near syncope episode, headache, nausea, dizziness, l...
12 hours post vaccine administration- vasovagal/near syncope episode, headache, nausea, dizziness, lightheadedness, trouble sleeping and intermittent "pins and needles feeling in hands and feet"
More
|
||||||
| 2823001 | 61 | M | WI | 01/27/2025 |
SMALLMNK SMALLMNK |
BAVARIAN NORDIC BAVARIAN NORDIC |
96867 96867 |
Arthralgia, Fatigue, Injection site erythema, Injection site induration, Injecti...
Arthralgia, Fatigue, Injection site erythema, Injection site induration, Injection site pain; Injection site pruritus, Injection site warmth, Myalgia
More
|
Pt has occupational risk of exposure to orthopoxviruses as individual who directly handle cultures o...
Pt has occupational risk of exposure to orthopoxviruses as individual who directly handle cultures or animals contaminated or infected with monkeypox virus. Jynneos booster given on 1/22/25 to left arm is noted to be red, indurated and slight warmness to area where vaccine was given. Redness measures 20 x 10 cm. Induration is 14cm long. Pt notes that he experienced joint pain, myalgia, and fatigue following Jynneos injection that improved on 1/23/25 evening. Pt notes injection site was itchy. Pt notes injection site caused a dull ache pain in the center of the induration. Discomfort was up to 6/10 on pain scale. Pt notes pain on 1/24/25 is much better at a 1-2/10.
More
|
||||||
| 2823002 | 67 | M | 01/27/2025 |
COVID19 |
MODERNA |
3043332 |
Expired product administered
Expired product administered
|
After Pt was vaccinated i noticed there was no Beyond Use date label from when vaccine was thawed. P...
After Pt was vaccinated i noticed there was no Beyond Use date label from when vaccine was thawed. Per Manufacturer and CDC there is a 60 day Beyond use date after being thawed. I followed with contacting our supply and figured it was delivered on 25 Nov 2024 and that because no one knew when it was that that it was 60 days from that date. I then called our med safety pharmacist and she followed up with the manufacturer which they advised to revaccinate.
More
|
|||||||
| 2823003 | 31 | M | WA | 01/27/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
B2451V1B |
Extra dose administered
Extra dose administered
|
Patient had already received 3 doses and should not have received this dose
Patient had already received 3 doses and should not have received this dose
|
||||||
| 2823004 | 22 | F | 01/27/2025 |
COVID19 |
MODERNA |
3043332 |
Expired product administered
Expired product administered
|
After Pt was vaccinated i noticed there was no Beyond Use date label from when vaccine was thawed. P...
After Pt was vaccinated i noticed there was no Beyond Use date label from when vaccine was thawed. Per Manufacturer and CDC there is a 60 day Beyond use date after being thawed. I followed with contacting our supply and figured it was delivered on 25 Nov 2024 and that because no one knew when it was that that it was 60 days from that date. I then called our med safety pharmacist and she followed up with the manufacturer which they advised to revaccinate. Pt is 26 weeks pregnant and estimated delivery date is 24 Feb 2025.
More
|
|||||||
| 2823005 | 41 | F | SC | 01/27/2025 |
COVID19 |
MODERNA |
|
Hysterectomy, Menstrual disorder, Ultrasound scan abnormal, Uterine leiomyoma
Hysterectomy, Menstrual disorder, Ultrasound scan abnormal, Uterine leiomyoma
|
I started having menstral issues and developed 5 large uterine fibroids. As a result, my uterus had ...
I started having menstral issues and developed 5 large uterine fibroids. As a result, my uterus had to be removed
More
|
โ | โ | ||||
| 2823006 | 4 | F | NH | 01/27/2025 |
DTAPIPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
T343J Y008280 |
Expired product administered; Expired product administered
Expired product administered; Expired product administered
|
Patient was administered two vaccines at her well child exam today on 1/27/27 of Kinrix and Proquad....
Patient was administered two vaccines at her well child exam today on 1/27/27 of Kinrix and Proquad. Both the Registered Nurse and Medical assistant verified the date of the vaccines with the impression todays date was 1/25/25. After administration, the kinrix vaccine was discovered to be expired. The patients provider APRN and the patient's father were informed.
More
|
||||||
| 2823007 | 72 | F | SC | 01/27/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
255t2 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient received 2 RSV vaccines unknowingly. Received first on 09/29/2023 and second 01/23/2025. Has...
Patient received 2 RSV vaccines unknowingly. Received first on 09/29/2023 and second 01/23/2025. Has not experienced any side effects so far.
More
|
||||||
| 2823008 | 39 | F | VA | 01/27/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
Mobility decreased, Pain in extremity
Mobility decreased, Pain in extremity
|
The day after getting the flu shot my arm was more sore than typical. It continued to get worse unti...
The day after getting the flu shot my arm was more sore than typical. It continued to get worse until I began to notice that my movement was more limited. It got to the point that I could not raise my arm more than about 10%.
More
|
||||||
| 2823009 | 80 | F | FL | 01/27/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient received duplication vaccine 14 months apart with NO adverse event or symptoms.
Patient received duplication vaccine 14 months apart with NO adverse event or symptoms.
|
||||||
| 2823010 | 71 | F | MA | 01/27/2025 |
FLU3 |
SEQIRUS, INC. |
388462 |
Urticaria
Urticaria
|
About 4 hours (7:00 pm). after the shot, I developed hives. They gradually increased until they wer...
About 4 hours (7:00 pm). after the shot, I developed hives. They gradually increased until they were everywhere except my feet and my head. They went away about 5:00 am the next morning. However, they returned the next evening (same places) and then the second round also went away about 7:00 the next morning. This time, they didn't return. My question is whether or not I should get a flu shot next year.
More
|